Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Study of DA-8159 in Subjects With Erectile Dysfunction

ClinicalTrials.gov ID: NCT00282607

Public ClinicalTrials.gov record NCT00282607. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 10:55 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Placebo-Controlled, Double-Blind, Parallel Design Phase 2 Dose Ranging Trial To Assess The Safety and Efficacy of DA-8159 Tablets in Male Subjects With Erectile Dysfunction.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study will be to evaluate the clinical efficacy and safety of DA-8159, an orally administered, potent and selective inhibitor of PDE5, versus placebo for the treatment of subjects with erectile dysfunction (ED).

Study identification

NCT ID
NCT00282607
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Dong-A PharmTech Co., Ltd.
Industry
Enrollment
300 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
19 Years to 75 Years
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 2005 (Type not available)
Primary completion
Not listed
Completion
Jun 2006 (Type not available)
Last update posted
Feb 28, 2007

2005 – 2006

United States locations

U.S. sites
15
U.S. states
10
U.S. cities
15
Facility City State ZIP Site status
Medical Affiliated Research Center Huntsville Alabama 35801 —
The Male Clinic Beverly Hills California 90212 —
South Orange County Laguna Woods California 92653 —
California Profession Research Newport Beach California 92660 —
West Coast Clinical Research Tarzana California 91356 —
Urology Research Options Aurora Colorado 80012 —
Connecticut Clinical Research Center Waterbury Connecticut 06708 —
South Florida Medical Research Aventura Florida 33180 —
Florida Foundation for Healthcare Research Ocala Florida 34474 —
Northeast Indiana Research, LLC Fort Wayne Indiana 46825 —
Drs. Werner, Murdock & Francis, P.A. , Urology Associates Greenbelt Maryland 20770 —
Accumed Research Associates Garden City New York 11530 —
Center for Urologic Research of Western New York Williamsville New York 14221 —
University Urological Researcgh Institute Providence Rhode Island 02904 —
Urology San Antonio Research San Antonio Texas 78229 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00282607, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 28, 2007 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00282607 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →